A Guidebook of Registration Application for Imported Biological Products |
A Guidebook of Registration Application for Imported Biological Products is the fourth guidebook of the China Pharmaceutical Guidebook Series. |
|
|
  |
|
Contact Information |
|
Access China Management Consulting Ltd
Nanjing
JiangSu -
China
86-13337715290
labwu.zengxian@gmail.com
|
|
|
 |
It will provide a detailed introduction of SFDA’s requirements for materials and clinical trials of registration application and approval for imported biological products. This guidebook will introduce SFDA’s requirements for materials and clinical trials of registration application for imported biological products in four parts and twelve chapters according to the existing a serial of regulations and guidelines.
Report Highlights
The classification of biological product registration
The material items for application of biological product registration
The requirements of material items for application of biological product registration
The requirements of clinical trial for application of biological product registration
The guideline for application of biological products for human gene therapy
The guideline for application of biological products for somatic cell therapy
The guideline for application of biological products for allergic therapy
The significant suggestions for overseas pharmaceutical manufacturers and producers looking to achieve a successful application for their biopharmaceuticals registration in China.
Many useful resources of law and regulations, including the Drug Administration Law of the People’s Republic of China, the Regulations for Implementation of the Drug Administration Law of the People’s Republic of China, the Chinese Good Clinical Practice of Pharmaceutical Products, the Chinese Good Manufacturing Practice for Pharmaceutical Products, the Form of Registration Application for Imported Drug, and so on.
Who should buy this report?
• Companies wishing to enter a lucrative drug market in China.
• Companies interested in understanding the latest Chinese regulations on application and approval for imported drug registration.
• Senior executive officers engaging regulatory and registration affairs for drugs.
Table of Contents
Table of Contents 2
Preface 4
Chapter 1. Introduction 7
Part 1. Therapeutic Biological Products 9
Chapter 2. Classification of Therapeutic Biological Product
Registration 9
Chapter 3. Material Items for Application of Therapeutic Biological
Product Registration 11
3.1. Comprehensive Materials 12
3.2. Research Materials of Pharmaceutics 14
3.3. Research Materials of Pharmacology and Toxicology 17
3.4. Materials of Clinical Investigation 19
3.5. Miscellaneous 20
Chapter 4. Requirements of Material Items for Application of
Therapeutic Biological Product Registration 21
4.1. The Form of Material Items 21
4.2. The Explanatory Notes of Material Items 24
Chapter 5. Requirements of Clinical Trial for Application of
Therapeutic Biological Product Registration 29
5.1. General Requirements of Clinical Trial 29
5.2．Special Requirements of Clinical Trial for Imported
Therapeutic Biological Products 30
Part 2. Prophylactic Biological Products 31
Chapter 6. Classification of Prophylactic Biological Product
Registration 31
Chapter 7. Material Items for Application of Prophylactic Biological
Product Registration 33
7.1. Comprehensive Materials 34
7.2. Summary and Evaluation of Research Results 36
7.3. Research Materials of Bacterial (Toxic) Seeds for Production Use 36
7.4. Research Materials of Cell Matrix for Production Use 37
7.5. Research Materials of Production Technique 38
7.6. Experimental Materials for Quality Study 39
7.7. Regulation Draft of Production and Assay, Drafting Explanation
of Regulation, Relevant Literature. 40
7.8. Records of Production and Assay for Samples to
Apply for Clinical Trial 40
7.9. Research Materials of Initial Stability Study 40
7.11. Plan and Scheme for Clinical Trial. 40
7.12. Summary of Pre-clinical Investigation 40
7.13. Summary of Relevant Literature for Clinical Trial. 40
7.14. Clinical Trial Reports, Draft of Informed Consent Form,
Approval Letter of Ethics Committee 41
7.15.Working Summary of Improving Production Technique
and Quality Standard, Experimental Materials of Pharmacological and
Toxicological Studies during Clinical Trials 41
7.16. Research Materials for Determining Preservation Condition
and Effective Life of Vaccines. 41
7.17. Modified Contents and Basis for Reviewed Regulation
of Production and Assay. 41
7.18. Records of Production and Assay for 3 Successive Batches
of Trial Products. 41
Chapter 8. Requirements of Material Items for Application of
Prophylactic Biological Product Registration 42
8.1. The Form of Material Items 42
8.2. The Explanatory Notes of Material Items 44
Chapter 9. Requirements of Clinical Trial for Application of
Prophylactic Biological Product Registration 46
9.1. General Requirements of Clinical Trial 46
9.2. Special Requirements of Clinical Trial for Imported
Prophylactic Biological Products 47
Part 3. Biological Products for Gene Therapy and Somatic Cell
Therapy 48
Chapter 10. Guideline for Application of Biological Products for Gene
Therapy 48
10.1. Comprehensive Materials 49
10.2. Research Contents for Project and Quality Control for Product 51
10.3. Clinical Investigations for Research Project and Product 57
Chapter 11. Guideline for Application of Biological Products for
Somatic Cell Therapy 60
11.1. Comprehensive Materials 62
11.2. Quality Control for Product 63
11.3. Clinical Investigations…………………………………………………..66
Part 4. Biological Products for Allergic Therapy 70
Chapter 12. Guideline for Application of Biological Products for
Allergic Therapy 70
12.1. Quality Control for Products 70
12.2. Requirements for Pre-clinical Investigation 76
12.3. Requirements for Clinical Trial 77
Chapter 13. Conclusion 78
Chapter 14. Appendices 81
14.1. The Drug Administration Law of the People’s Republic of China 81
14.2. The Regulations for Implementation of the Drug Administration
Law of the People’s Republic of China 108
14.3. The Good Clinical Practice of Pharmaceutical Products 135
14.4. The Good Manufacturing Practice for Pharmaceutical Products 155
14.5. Form of Registration Application for Imported Drug 174
14.6. References 179
14.7. Resources 180
14.8. Author’s Biography 181
14.9. Company’s Description 182
Access China Management Consulting Ltd
Published Date: January 2012
Page Count: 182
Unit Price: US$ 750
Site License: US$3500
Format: Electronic PDF copy
For more information, please visit:
http://www.accesschinainfo.com/articleview.php?id=196
For more information, visit: http://www.accesschinainfo.com/articleview.php?id=196
|
| Related Tags: Biological Products, Chinese Biological Products, Chinese Biological Products Registration |
Disclaimer
If you have any questions regarding information in this press release, please contact the person listed in the Contact / Company information box of this page. Please do not attempt to contact Market Press Release. We will be unable to assist you with any information regarding this release. Market Press Release disclaims any content contained in this press release.
|
Business
![[Valid RSS]](images/valid-rss-rogers.png "Validate my RSS feed")
